Allocation of ordinary bearer shares of series T of the Company

Current report No. 38/2024

Date of preparation: 3 December 2024.

Subject: Allocation of ordinary bearer shares of series T of the Company

Legal basis: Article 17(1) MAR - confidential information.

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the ‘Company’), with reference to: current report no. 35/2024 of 20 November 2024, current report no. 36 of 20 November 2024 and current report no. 37/2024 of 22 November 2024, announces that on 3 December 2024, the Company's Management Board adopted a resolution on the allotment of 822,467 series T ordinary bearer shares of the Company with a nominal value of PLN 0.10 each and with a total nominal value of PLN 82,246.70 (‘Series T Shares’). At the same time, the Company announces that to date share subscription agreements have been concluded with investors taking up Series T Shares and the required cash contributions have been made in full by all those subscribing for Series T Shares.

ADDITIONAL INFORMATION

The current report has been prepared solely for the purpose of fulfilling the obligations under Article 17 paragraph 1 of the EU Regulation No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse Regulation and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC MAR, as the Company considered the above information as meeting the criteria of confidential information within the meaning of Article 7 MAR. This report does not serve in any way, directly or indirectly, to promote the offer, subscription or purchase of the Series T Shares and does not constitute advertising or promotional material prepared or published by the Company for the purpose of promoting the T Share Offer or for the purpose of encouraging investors, directly or indirectly, to purchase or to purchase or subscribe for Series T Shares.